MAJOR Supreme Court Ruling

Texas

The Texas Supreme Court has upheld that the state may continue abuse investigations into the parents of transgender kids who are receiving specific gender modifying treatments and pharmaceuticals. Texas Governor Greg Abbott authorized several companies to investigate reports of kids receiving transgender treatment for child abuse in February.

The investigations were temporarily stopped after a claim was submitted by the family and physician of a 16-year-old biological male who ‘identifies’ as female, who were among the very first to be scrutinized under the new orders.

While the court’s ruling will enable the examinations into other families to continue, the examination into the family who filed the fit stays halted under an injunction since it might cause “irreparable harm,” according to a report from the New York Times.

In a 12-page opinion, the court ruled that the court of appeals had actually abused its discretion by utilizing Guideline 29.3 to release a statewide order.

In February, Texas Attorney General Ken Paxton recently asserted that a variety of elective treatments for gender alteration are unlawful for minors in the state, including reassignment surgical treatments that can cause sterilization, mastectomies, eliminations of otherwise healthy body parts, and administration of puberty-blocking drugs or supraphysiologic doses of testosterone or estrogen.

One day after Paxton released his opinion, the governor purchased multiple agencies to begin examining moms and dads supplying their children with those procedures for abuse.

“Texas law imposes reporting requirements upon all licensed professionals who have direct contact with children who may be subject to such abuse, including doctors, nurses, and teachers, and provides criminal penalties for failure to report such child abuse,” Gov. Abbott said in a letter to the Department of Family and Protective Services. The letter was also sent to the Health and Human Services Commission, Texas Medical Board, and Texas Education Agency.

According to the report from the Times, “in March, a district judge, Amy Clark Meachum in Travis County, ordered all such investigations to stop, pending a trial. She found that the governor’s order had been improperly adopted and violated the State Constitution. An appeals court allowed the temporary injunction to remain in place.”

“Mr. Abbott, along with the state’s attorney general, Ken Paxton, brought the case to the Texas Supreme Court, arguing that the investigations, on their own, were not an ‘injury’ and that the district court had overstepped its authority in preventing them. All nine members of the state’s highest court are Republican; five were appointed by Mr. Abbott,” the report continued.

In action to Abbott’s order, medical facilities throughout the state stopped using hormonal agent treatments for minors.

Attorney General Paxton revealed an examination into 2 pharmaceutical businesses that allegedly promote using hormone-blocking drugs for children earlier this year. The drugs are not authorized by the FDA for this function.

Paxton’s office is looking into whether or not Endo Pharmaceuticals, Inc. and AbbVie Inc. violated the Texas Deceptive Trade Practices Act by promoting utilizing the medications Supprelin LA and Lupron Depot for kids whose parents declare that they are transgender.

According to a press release from the Attorney general of the United States,

“Supprelin LA and Lupron Depot are approved to treat children with Central Precocious Puberty (CPP), when the puberty process begins prematurely. And Vantas, along with other forms of Lupron, has been prescribed for palliative treatment of prostate cancer. These drugs are now being used to treat gender dysphoria even though they are not approved for such use by the Food and Drug Administration (FDA). Gender dysphoria is a diagnosed mental disorder in which a person experiences significant distress related to a strong desire to be of another biological sex.”

“The manufacture, sale, prescription, and use of puberty blockers on young teens and minors is dangerous and reckless,” Attorney General Paxton said in the statement. “These drugs were approved for very different purposes and can have detrimental and even irreversible side effects. I will not allow pharmaceutical companies to take advantage of Texas children.”

H/T Timcast

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts